About Protein Genomics

Home | About Us | Elastatropin® | News | Links | Contact

Management Team

BURT D. ENSLEYBURT D. ENSLEY, Ph.D., is the founder of Protein Genomics, Inc. and DermaPlus, Inc., Arizona-based biotechnology companies involved in wound healing, tissue regeneration and skin care. His professional career began in 1981 when he was hired by Amgen, Inc., a start-up biotech firm in Thousand Oaks, Calif., that he helped become the largest such company in the world within 10 years. Amgen now has 40,000 employees and $12 billion in annual revenue.

In 1989, Dr. Ensley left Amgen to serve as director of advanced technologies for Envirogen, Inc. There, he led research and field demonstrations of biological and physical/chemical technologies for the treatment of hazardous wastes from the Company's inception until its Public offering in 1992. He then became a founder and the President, CEO and Director of Phytotech, Inc., a biotechnology company using plants for the treatment of contaminated soil and water. He raised financing for Phytotech of $5 million in equity and $2 million in debt from inception to sale of the business in June 1999.

In 1999, Dr. Ensley founded Nucycle Therapy, Inc. a biotechnology company involved in discovering, developing and commercializing unique nutritional supplements and high value nutraceutical and therapeutic products from plants. He served as the Company's CEO from 1999 to 2001. The Company was able to scale-up the manufacture of 50 million doses of plant-based nutritional mineral supplements, and was sold to Integrated Biopharma, a publicly traded entity, in 2001.

Dr. Ensley was elected to Fellowship in the American Academy of Microbiology in recognition of his research accomplishments. His professional affiliations have included membership in the Board of Directors and Co-Chair of The BIO5 Institute at the University of Arizona; Board of Trustees at the Biotechnology Council of New Jersey; Board of Directors of the Natural History Museum at the University of Kansas; the American Association for the Advancement of Science; the American Society for Microbiology; service on the National Research Council Committee on Catalysis; and on the Biology Directorate Advisory Committee of the National Science Foundation. He is an Adjunct Professor at Northern Arizona University.

He holds his Ph.D. degree in microbiology from the University of Georgia (1979), his master's degree in biology from the University of New Mexico (1976), and bachelor's degree in biology from the University of New Mexico (1974).

Dr. Ensley has 30 publications in the peer-reviewed scientific literature and holds 20 issued and 2 pending US patents.

Dr. Ensley served in the US Army from August 1968 until May, 1971, graduating from the MACV Recondo School and serving with the 5th Special Forces Group, 1st Special Forces (Airborne) in Nha Trang, Vietnam. He was decorated twice (BSM and ARCOM) for service in combat.

He currently resides in Sedona, Ariz., with his wife, Carolyn, and their four cats. In his spare time, he enjoys gardening, cooking and tinkering with old cars.

ROBERT S. KELLARROBERT S. KELLAR, is the Chief Science Officer for Axolotl Biologix. He has over 16 years of experience in the development and regulatory approval of medical devices, cell-based products, and regenerative medicine and tissue-engineered technology. He has 29 peer-reviewed publications and 3 issued US patents. He received his PhD from the University of Arizona in 2001.

Dr. Kellar currently serves on the Scientific Advisory Board for MyoStim, and is on the Faculty in the Center for Bioengineering Innovation (CBI), Biological Sciences and Mechanical Engineering at Northern Arizona University. Dr. Kellar has helped to co-found a number of companies including Development Engineering Sciences, a biomedical consulting firm, Flagship Biosciences, a digital pathology company, and Autogenesis Corporation, a wound healing company. He serves as an Advisory Board Member for Protein Genomics, a protein polymer medical device company, and the California Stock Exchange.

Dr. Kellar's previous roles include: VP of Research and Development at Histogen, Inc. in San Diego, CA, Product Specialist at W.L. Gore and Associates in Flagstaff, AZ, and Lead Scientist and Project Manager at Advanced Tissue Sciences, Inc. in La Jolla, CA..

© 2008 Protein Genomics, Inc. All Rights Reserved.